AMRI will be jumping into its autumn schedule of events, starting with the 2014 ChemOutsourcing show, which is the largest U.S.-based API show attracting 700-800 chemists annually from the pharmaceutical, biotech, and chemical industries. From September 15-18, AMRI representatives are available to chat more about our offerings and expand on some of our recent business moves. Please make sure to contact us for a meeting or drop by our booth (#85) to find out more.
With demonstrated success in Large Scale API and Drug Product Manufacturing, we offer our customers the preeminence and scale to support the chemical development, clinical formulation development, cGMP manufacture and cGMP aseptic formulation and filling of complex Active Pharmaceutical Ingredients (API), including potent, controlled substances, biologics, peptides, steroids, and cytotoxic compounds.
One recent business move, the acquisition of Cedarburg Pharmaceuticals, adds to depth and breadth of our API R&D and manufacturing capabilities in technically complex API. Cedarburg also brings an attractive development pipeline with multiple late-stage products and scalable infrastructure for future growth.
At ChemOutsourcing, AMRI will be participating on a panel on Tuesday, and will also be giving a 10-minute talk on Wednesday. Be sure to check out the event details below. Also, be sure to further reference the show’s agenda here.
AMRI at ChemOutsourcing
Panel Discussion: “Supplier-Customer Problem Solving in Drug Discovery & Medicinal Chemistry Collaborations”
AMRI Panelist: Susan Billings, Ph.D., Business Development Manager, AMRI
Time: 3:45-4:30 p.m.
Date: Tuesday, Sept. 16, 2014
Location: Track A
Exhibitor Talk: “Expanding Your Access to Cutting-Edge Technologies & Expertise, from Early Discovery Through Commercial Manufacturing”
AMRI Presenter: Susan Collins, Senior Director, Global Business Development – Discovery and Preclinical Services, AMRI
Time: 4:10 p.m.
Date: Wednesday, Sept. 17, 2014
Location: Track C in the Shrewsbury Room